Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Jan 27, 2011

Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer
Jan 5, 2011

Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
Dec 9, 2010

Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium

Final 10-year combination chemotherapy adjuvant survival data, studies of investigational agent iniparib to be featured at breast cancer symposium
Nov 18, 2010

Call to Action Paves Path for Addressing the National Diabetes Epidemic
Oct 1, 2010

Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet

- Results of the Phase III TROPIC global study published -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.